ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse
RIVASTIGMINUM
Active substance (INN) · ATC N06DA03 · 24 products authorised in Romania
1
Protocols it appears in
As a medicine of the protocol (in the title) or only mentioned in the text
2
Authorised brand products (ANMDM)
The Romanian register of medicines for human use, updated daily
| Brand name | Form | Strength | Holder | ATC | Rx |
|---|---|---|---|---|---|
| EVERTAS 4,6 mg/24 h | PLASTURE TRANSDERMIC | 4,6mg/24h | ZENTIVA K.S. - REPUBLICA CEHA | N06DA03 | PRF |
| EVERTAS 9,5 mg/24 h | PLASTURE TRANSDERMIC | 9,5mg/24h | ZENTIVA K.S. - REPUBLICA CEHA | N06DA03 | PRF |
| EXELON 13,3 mg/24h | PLASTURE TRANSDERMIC | 13,3/24h | NOVARTIS EUROPHARM LIMITED - IRLANDA | N06DA03 | PR |
| EXELON 4,6 mg/24h | PLASTURE TRANSDERMIC | 4,6mg/24h | NOVARTIS EUROPHARM LIMITED - IRLANDA | N06DA03 | PR |
| EXELON 9,5 mg/24h | PLASTURE TRANSDERMIC | 9,5mg/24h | NOVARTIS EUROPHARM LIMITED - IRLANDA | N06DA03 | PR |
| NIMVASTID 1.5mg | CAPS. | 1.5mg | KRKA, D.D., NOVO MESTO - SLOVENIA | N06DA03 | P-RF/R |
| NIMVASTID 3mg | CAPS. | 3mg | KRKA, D.D., NOVO MESTO - SLOVENIA | N06DA03 | P-RF/R |
| NIMVASTID 4.5 mg | CAPS. | 4.5mg | KRKA, D.D., NOVO MESTO - SLOVENIA | N06DA03 | P-RF/R |
| NIMVASTID 4.5 mg | COMPR. ORODISPERSABILE | 4.5mg | KRKA, D.D., NOVO MESTO - SLOVENIA | N06DA03 | P-RF/R |
| NIMVASTID 6 mg | CAPS. | 6mg | KRKA, D.D., NOVO MESTO - SLOVENIA | N06DA03 | P-RF/R |
| NIMVASTID 6mg | COMPR. ORODISPERSABILE | 6mg | KRKA, D.D., NOVO MESTO - SLOVENIA | N06DA03 | P-RF/R |
| RIDAXIN 1,5 mg | CAPS. | 1,5mg | NEOLA PHARMA S.R.L. - ROMANIA | N06DA03 | PRF |
| RIDAXIN 3 mg | CAPS. | 3mg | NEOLA PHARMA S.R.L. - ROMANIA | N06DA03 | PRF |
| RIVASTIGMINA ARENA 1,5 mg | CAPS. | 1,5mg | ARENA GROUP S.A. - ROMANIA | N06DA03 | PRF |
| RIVASTIGMINA ARENA 3 mg | CAPS. | 3mg | ARENA GROUP S.A. - ROMANIA | N06DA03 | PRF |
| RIVASTIGMINA ARENA 4,5 mg | CAPS. | 4,5mg | ARENA GROUP S.A. - ROMANIA | N06DA03 | PRF |
| RIVASTIGMINA ARENA 6 mg | CAPS. | 6mg | ARENA GROUP S.A. - ROMANIA | N06DA03 | PRF |
| RIVASTIGMINA SANDOZ 1,5 mg | CAPS. | 1,5mg | SANDOZ GMBH - AUSTRIA | N06DA03 | P-RF/R |
| RIVASTIGMINA SANDOZ 2mg/ml | SOL. ORALA | 2mg/ml | SANDOZ GMBH - AUSTRIA | N06DA03 | PR |
| RIVASTIGMINA SANDOZ 3mg | CAPS. | 3mg | SANDOZ GMBH - AUSTRIA | N06DA03 | P-RF/R |
| RIVASTIGMINA SANDOZ 4,5mg | CAPS. | 4,5mg | SANDOZ GMBH - AUSTRIA | N06DA03 | P-RF/R |
| RIVASTIGMINA SANDOZ 6mg | CAPS. | 6mg | SANDOZ GMBH - AUSTRIA | N06DA03 | P-RF/R |
| RIVASTIGMINA STADA 4,6 mg/24 ore | PLASTURE TRANSDERMIC | 4,6mg/24h | STADA HEMOFARM S.R.L. - ROMANIA | N06DA03 | PRF |
| RIVASTIGMINA STADA 9,5 mg/24 ore | PLASTURE TRANSDERMIC | 9,5mg/24ore | STADA HEMOFARM S.R.L. - ROMANIA | N06DA03 | PRF |
| RIVASTIGMINA TEVA 2 mg/ml | SOL. ORALA | 2mg/ml | TEVA PHARMACEUTICALS S.R.L. - ROMANIA | N06DA03 | PRF |